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Since the conception of the National Cancer Act
nearly 30 years ago, extraordinary advances in cancer
research have helped decrease the number of lives lost
to cancer. Remarkable technology developments and
novel cellular discoveries have broadened our under-
standing of cancer – an understanding that has helped
improve how and when cancer is detected. Using sen-
sitive technologies to unveil subtle changes in a cell’s
molecular circuitry, scientists are using these molecu-
lar changes as signposts along the path to cancer. Sci-
entists and clinicians are assessing if changes that pre-
clude a cell’s transformation to cancer can be used in
a practical way to identify individuals with early stage
cancer or who are at risk for developing cancer.
One of the most important effectors of the clinical
outcome of cancer is whether it is detected at an early
stage. The use of sensitive technologies and a bet-
ter understanding of cancer are helping scientists and
clinicians do just that – detect early stage disease. In
thebeginningstagesofdevelopment,precancerousand
cancerous lesions are localized, and the tumor is most
amenable to eradication. Tools to ﬁnd cancer at such
an early stage would then offer a unique window of
opportunity during which intervention could prevent
progression to widespread and perhaps fatal disease.
Improvementsin cancer detection research and sub-
sequent reductions in cancer mortality have been real-
ized through increased emphasis on cancer prevention
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research. Among the highest priorities of the National
Cancer Institute is the support of research to improve
the health of the public by decreasing the incidence,
mortality, and morbidity of cancer. The National Can-
cer Institute’s Division of Cancer Prevention is fulﬁll-
ing this mission by engaging basic and clinical scien-
tists, epidemiologists, and statisticians in a search for,
and validation of, early cancer biomarkers.
At the forefront of advances in prevention science
andbiomarkerresearchistheEarlyDetectionResearch
Network(http://cancer.gov/edrn),a collaborativeeffort
supported by the Division of Cancer Prevention. The
Network was assembled into a four-component, sci-
entiﬁc consortium from the recommendations of the
National Cancer Institute’s the Early Detection Imple-
mentation Group in 1998. The careful design of the
Network promotes the development and validation of
biomarkersforearlycancerandriskassessmentbypro-
viding a unique model for collaborative research. This
Networkhasthedistinctionofpioneeringthisapproach
to biomarker research and is the only forum of its kind
for biomarker development and validation.
The annualworkshopsponsoredbythe EarlyDetec-
tionResearchNetworkprovidesaforumforinteraction
and collaboration between leading cancer researchers
from around the world. Investigators and liaisons in
this consortium meet regularlyto discuss how to better
decipher the molecular circuitry of cells and apply this
understanding to the earlier detection of cancer. Us-
ing both the unconventionalapproach to biomarker re-
search through scientiﬁc consortia and facilitating the
regular interaction of leading experts, the Network is
pursing biomarker development and validation at an
unprecedentedpace.
AttheﬁrstscientiﬁcworkshoporganizedbytheNet-
work in September 2000, Network investigators pre-
sented scientiﬁc research ﬁndings that detailed the lat-
est advances and emerging issues in biomarker re-
search. The two-day meeting addressed six session
topics, including Advances in Organ Speciﬁc Molecu-
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lar Detection, Correlative Clinical Studies, Computa-
tional Analysis and Statistics, Informatics, Emerging
Issues and Technology for Biomarkers of Risk, and
Technologies within the Network. More than a dozen
speakers and over 60 abstracts fostered discussions on
these issues and other key challenges of the Network.
The abstracts presented in this issue of Disease Mark-
ers document the research highlighted and presented
at the ﬁrst scientiﬁc conference of the Early Detection
Research Network.
Through regular collaborations facilitated by the
Network, investigators can face the challenges of
biomarker research in a venue that facilitates commu-
nication and intellectual exchange. Challenges of cre-
atingnovelapproachestovalidationstudies,improving
informaticsandinformationﬂow,standardizingdatare-
porting, generating statistical and computational tools,
and standardizing reagents and assays complicate the
development and validation of biomarkers for early
cancer and risk assessment. Through the merged ex-
pertise of basic biologists, clinicians, epidemiologists,
and statisticians, Network investigators are developing
solutionstothebarriersthatplaguebiomarkerresearch.
Substantial headway in biomarker development has
been made within the ﬁrst year of the Network’s oper-
ation, and the rapid progress documentedin these pub-
lished abstracts is a testament to the collaborative ap-
proach to research. Barriers are being overcome, col-
laborationsarebeingforged,andabetterunderstanding
themolecularcircuitryofcancercellsis beingpursued.
Previously unknown puzzle pieces that once thwarted
attempts to reduce mortality from cancer are falling
into place, and the Early Detection Research Network
is well poised to ﬁnd additional missing pieces. The
Network provides both an opportunity and a challenge
for the scientiﬁc community – an opportunity to make
scienceworkforpeopleandachallengetomakethispi-
oneeringmodel of collaborationa productivescientiﬁc
construct that others will emulate.Submit your manuscripts at
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